NewsSource: EClinCloud

Register Now | Join the EClinCloud 2026 User Conference in Shanghai on May 13

3 min readEClinCloud Editorial Team
Article image

Source: EClinCloud. Author: EClinCloud.

Article image

The EClinCloud User Conference was first held in 2023.


We have always believed that true innovation grows by standing alongside users. As such, it is more than a product launch—it is an open platform connecting EClinCloud with industry partners. Here, we bring together practical insights from across the field to explore the path forward for digital and intelligent clinical research.


In 2026, AI in clinical research is moving from "testing the waters" to "diving deep."


To address the industry's real-world demand for artificial intelligence applications, we will host the 2026 User Conference in Shanghai on May 13, spotlighting cutting-edge AI practices in clinical research. Under the theme "AI-Led, A New Chapter Opens," the conference will span emerging trends, real-world case studies, technological breakthroughs, and practical implementation pathways as we open this next chapter together with industry partners.


Article image
01
 Focused on AI: Proven in Real-World Practice

Rather than discussing AI in the abstract, we focus on practical implementation.

Gain an early understanding of AI technology trends and stay ahead of the curve

Scenario-based demonstrations of intelligent applications in tools such as eCOA/EDC

Real-world case studies demonstrating AI-driven gains in clinical trial efficiency and quality

Practical skills and experience shared by frontline users—hear how your peers are putting AI to work

02
 Industry Leaders: Meet the Pioneers

Founders and CEOs of leading pharmaceutical and biotech companies, seasoned clinical research practitioners, and AI leaders from major technology firms will all gather here.

Hear the strategic thinking behind their successes alongside firsthand experience

Cross-industry insights to help break down information silos

In-person networking with valuable opportunities to engage directly with senior executives

03
 Intelligent Throughout: An Immersive Digital Experience

Our digital and intelligent gathering for clinical research is ready—we look forward to welcoming you.

Live AI interactive experiences

Interactive welcome gifts

Tech-themed live performances


Article image


15:00-15:30

Event Check-In


15:30-15:55

New Strategic Chapter
Dr. Qin Long Founder & CEO, EClinCloud


15:55-16:15

Full-Suite AI Capability Upgrade

EClinCloud Product Team


16:15-16:25

Key Product Value Launch

Senior Product Consultant, EClinCloud


16:25-16:45

Pharmaceutical Company Practice Sharing
Pharmaceutical Company Representative

16:45-17:00

User Practice Sharing

User Representative


17:00-17:45

Panel Discussion: "Build with AI: Value Reconstruction and Business Model Innovation"

Pharmaceutical Company Representatives / Investment Institution Representatives / AI Technology Experts, and More


17:45-18:15

Tea Break


18:15-21:00

Networking Dinner


Blue promotional real estate event full-screen mobile poster (5).png


The first 50 guests who register and pass review before April 30 will receive an additional early-bird surprise gift on top of the conference check-in gift, while supplies last, on a first-come, first-served basis!

📌 How to Claim: You will be notified by SMS on May 6 and can collect your gift at on-site check-in.

📌 Limited spots available, first-come, first-served

Image

Ongoing lucky draws during the networking dinner

QR code (2.png

Scan the QR Code to Register Now

Registration Is Subject to Review

(Please be sure to enter your work email address)


<Highlights from Past User Conferences>







About EClinCloud


EClinCloud is a leading AI company in the clinical research industry. Driven by AI, it builds an integrated intelligent clinical cloud platform and endpoint assessment technologies, providing global pharmaceutical companies and research organizations with technology products including eCOA, CTMS, eTMF, EDC, RTSM, IRC, and RM, alongside scale management, linguistic validation, rater training, and data quality analysis services to deliver efficient, precise digital solutions. Leveraging AI predictive models and an intelligent data platform, EClinCloud dynamically evaluates and helps improve the success rate of drug clinical trials, helping shorten drug and device development cycles for the benefit of patients.







Article image






Read the original WeChat post

Related reading

WeChat image 2026-11-11_150855_109.pngNews6 min readWorld COPD Day | Imaging Assessment in COPD Clinical ResearchNovember 13-15, 2026. November 18, 2026 marks the 25 World COPD Day, with this year's theme: Early Diagnosis and Management for a Better Life. Chronic Obstructive Pulmonary Disease (COPD) is a preventable and treatable disease characterized by persistent airflow limitation. COPD is closely related to chronic bronchitis and emphysema [1]. We have previously covered COAs for COPD,Article imageNews3 min readAddressing Complex Challenges in Clinical Research: EClinCloud’s Full-Lifecycle AI Enablement Attracts AttentionFrom November 13–15, the 2026 Nucleic Acid Therapy and Intelligent Biomedicine Industry Innovation Conference, academically guided by the Chinese Stroke Association and hosted by the Yuanshu Brain Science Research Center, was held in Fuzhou. Dr. Qin Long, founder and CEO of EClinCloud, was invited to deliver a keynote speech titled “Practice and Application of AI in Clinical Research,” sharing insights on the development trends of AI-enabled new drug R&D and the practice of AI throughout the clinical research process, which attracted enthusiastic attention from the attending guests. 01 Current Landscape of AI-Enabled New Drug R&D: AI is demonstrating application value in multiple segments of new drug R&D, including target discoverySAPA-China 2026 CNS Forum on-site photo 1News3 min readFocusing on CNS Clinical Endpoint Assessment: EClinCloud Shares eCOA and IRC PracticesAt the CNS Forum of the SAPA-China 2026 Pharmaceutical Industry Conference, Zheng Liangyan, Medical Director at EClinCloud, shared approaches to applying eCOA and IRC, covering challenges, regulatory requirements, and practical implementation in central nervous system (CNS) disease clinical research.